143 related articles for article (PubMed ID: 10962136)
41. Norplant users with irregular bleeding. Ultrasonographic assessment and evaluation of serum concentrations of estradiol and progesterone.
Kaewrudee S; Taneepanichskul S
J Reprod Med; 2000 Dec; 45(12):983-6. PubMed ID: 11153258
[TBL] [Abstract][Full Text] [Related]
42. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
43. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
Vincent AJ; Zhang J; Ostor A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2000 Jan; 15(1):123-30. PubMed ID: 10611200
[TBL] [Abstract][Full Text] [Related]
44. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.
Abdel-Aleem H; d'Arcangues C; Vogelsong K; Gülmezoglu AM
Cochrane Database Syst Rev; 2007 Apr; (2):CD003449. PubMed ID: 17443526
[TBL] [Abstract][Full Text] [Related]
45. The introduction of a new contraceptive; two years experience with Norplant.
Davie J; Hiremath K; Glasier A
Health Bull (Edinb); 1996 Jul; 54(4):314-7. PubMed ID: 8783485
[TBL] [Abstract][Full Text] [Related]
46. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
Glasier AF; Wang H; Davie JE; Kelly RW; Critchley HO
Fertil Steril; 2002 Feb; 77(2):366-72. PubMed ID: 11821099
[TBL] [Abstract][Full Text] [Related]
47. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
Rogers PA; Au CL; Affandi B
Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding.
d'Arcangues C; Piaggio G; Brache V; Aissa RB; Hazelden C; Massai R; Pinol A; Subakir SB; Su-juan G;
Contraception; 2004 Dec; 70(6):451-62. PubMed ID: 15541406
[TBL] [Abstract][Full Text] [Related]
49. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
50. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD; Landgren BM; Rymer J; Helmond FA;
Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
[TBL] [Abstract][Full Text] [Related]
51. Women's satisfaction with Norplant as compared with oral contraceptives.
Eilers GM; Swanson TK
J Fam Pract; 1994 Jun; 38(6):596-600. PubMed ID: 8195734
[TBL] [Abstract][Full Text] [Related]
52. Changes in vascular basement membrane in the endometrium of Norplant users.
Hickey M; Simbar M; Markham R; Young L; Manconi F; Russell P; Fraser IS
Hum Reprod; 1999 Mar; 14(3):716-21. PubMed ID: 10221702
[TBL] [Abstract][Full Text] [Related]
53. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium.
Roopa BA; Loganath A; Singh K
Hum Reprod; 2003 Sep; 18(9):1809-19. PubMed ID: 12923132
[TBL] [Abstract][Full Text] [Related]
54. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
55. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives.
Vincent AJ; Salamonsen LA
Hum Reprod; 2000 Aug; 15 Suppl 3():135-43. PubMed ID: 11041229
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical detection of cathepsin D in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle.
Lau TM; Affandi B; Rogers PA
Mol Hum Reprod; 1996 Apr; 2(4):233-7. PubMed ID: 9238685
[TBL] [Abstract][Full Text] [Related]
57. Menstrual bleeding patterns in Chinese women using the Norplant subdermal implant.
Fan M; Sujuan G
Hum Reprod; 1996 Oct; 11 Suppl 2():14-9. PubMed ID: 8982740
[TBL] [Abstract][Full Text] [Related]
58. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
[TBL] [Abstract][Full Text] [Related]
59. Tamoxifen treatment of bleeding irregularities associated with Norplant use.
Abdel-Aleem H; Shaaban OM; Amin AF; Abdel-Aleem AM
Contraception; 2005 Dec; 72(6):432-7. PubMed ID: 16307966
[TBL] [Abstract][Full Text] [Related]
60. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
Haugen MM; Evans CB; Kim MH
J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
